Inventor · Scarsdale, NY, US

Jesper Gromada

47Patents
6h-index
52Co-inventors
68Inventor score

Filing activity: Jul 30, 2014 → Aug 29, 2023

Most-cited inventions

PatentTitleAreaCited byStatus
US9644018B2 Antibody modulators of APLNR Chemistry; Metallurgy 11 Active
US10023644B2 Antigen-binding proteins that activate the leptin receptor Chemistry; Metallurgy 10 Active
US10787647B2 HSD17B13 variants and uses thereof Physics 9 Active
US9718881B2 Anti-Activin A antibodies and uses thereof Chemistry; Metallurgy 7 Active
US10253102B2 Antigen-binding proteins that activate the leptin receptor Chemistry; Metallurgy 6 Active
US10618968B2 Antigen-binding proteins that activate the leptin receptor Chemistry; Metallurgy 6 Active
US10961583B2 Inhibition of HSD17B13 in the treatment of liver disease in patients expressing the PNPLA3 I148M variation Chemistry; Metallurgy 5 Active
US9657099B2 Anti-glucagon antibodies Chemistry; Metallurgy 5 Active
US10550192B2 Antigen-binding proteins that antagonize leptin receptor Chemistry; Metallurgy 4 Active
US10526403B2 Anti-activin A antibodies and uses thereof Chemistry; Metallurgy 4 Active
US10155811B2 APLNR modulators and uses thereof Chemistry; Metallurgy 2 Active
US10189901B2 Methods for improving cardiac function by administering an antibody that activates APLNR Chemistry; Metallurgy 2 Active
US11535675B2 Antigen-binding proteins that antagonize leptin receptor Chemistry; Metallurgy 2 Active
US11608381B2 Methods of treatment using a leptin receptor agonist antibody Chemistry; Metallurgy 2 Active
US11702700B2 Inhibition of HSD17B13 in the treatment of liver disease in patients expressing the PNPLA3 I148M variation Chemistry; Metallurgy 2 Active
US11306148B2 Anti-NPR1 antibodies and uses thereof Chemistry; Metallurgy 2 Active
US10626173B2 Method for treating pathological angiogenesis by administering an antibody that inhibits APLNR Chemistry; Metallurgy 2 Active
US11820826B2 Anti-NPR1 antibodies and uses thereof Chemistry; Metallurgy 1 Active
US10442856B2 Methods of treating obesity with anti-ANGPTL8 antibodies Chemistry; Metallurgy 1 Active
US11485958B2 HSD17B13 variants and uses thereof Physics 1 Active
US11180757B1 17β-hydroxysteroid dehydrogenase type 13 (HSD17B13) iRNA compositions and methods of use thereof Chemistry; Metallurgy 1 Active
US11045522B2 Glucagon-like peptide 1 receptor agonists and uses thereof Chemistry; Metallurgy 1 Active
US11834500B2 Bispecific antigen binding molecules that bind leptin receptor and/or GP130, and methods of use thereof Chemistry; Metallurgy 1 Active
US11753628B2 HSD17B13 variants and uses thereof Physics 1 Active
US10548302B2 Fibrillin-1 mutations for modeling neonatal progeroid syndrome with congenital lipodystrophy Human Necessities 1 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.